METHOTREXATE
Item | Value |
---|---|
Approval req'd? | No |
Available Stat? | All requests treated as Stat |
Test code | MTX |
Performed by? | Chemistry |
Sendout? | No |
Price range | $$ |
In House Availability | 24 hours/ 7 days |
Method | Competitive immunoassay |
Container type | Red or green top non gel tube. Lavender top tube acceptable. The same specimen type should be used for all measurements from an individual patient. |
Amount to Collect | 1 mL |
Collection Instructions | The sampling time of methotrexate will be dependent on dose, duration of infusion, and clinical status of the patient. Consult specific treatment protocols for sampling time. Protect from light during collection, storage and shipment. Serum or plasma need to be separated from cells within 2 hours of collection. Specimens from patients who have received glucarpidase (carboxypeptidase G2) as a methotrexate rescue therapy should not be sent to the laboratory for testing with this method. This results in falsely elevated methotrexate concentrations due to interference by a metabolite of methotrexate that is produced when glucarpidase is administered; it remains in the circulation for 5-7 days. |
Sample type | Blood |
Preferred volume | 0.5 mL serum or plasma |
Units | µmol/L |
Normal range | Methotrexate (MTX) interpretation depends on dosing and draw times as well as the target level for the disease being treated. MTX levels in excess of 50 µmol/L at 24 hours, 10 µmol/L at 48 hours, and 0.5 µmol/L at 72 hours portend potential toxicity. Non-toxic drug concentrations after 72 hours are usually less than 0.1 µmol/L. |
Stability | 24 hours at room temperature, two weeks refrigerated |
Interferences | Specimens from patients who have received carboxypeptidase G2 (CPDG2) for MTX rescue contain a hydrolysis fragment of MTX (DAMPA) that can cross-react with the antibody used in this assay resulting in a falsely elevated MTX measurement. After CPDG2 administration DAMPA may continue to circulate for at least 5-7 days before accurate measurements of serum MTX can be determined using this assay. This assay crossreacts slightly with triamterene and trimethoprim, however these drugs may be contraindicated for MTX treatment due to additional adverse effects if co-administered. |
Turn around times | 2 hours |
CPT coding | 80299 |
Last Updated | 5/25/2013 10:54:18 AM |